Cuba to fast-track boosters as Omicron looms
HAVANA: Cuba will give booster shots to its entire population in January, according to a report in state-run media, in a bid to keep the highly contagious Omicron variant of the coronavirus at bay.
Health authorities in the island, heavily dependent on tourism, last week reported a 35 per cent week-on-week jump in coronavirus cases.
As of Tuesday, they had registered at least 44 cases of Omicron, though both infections and deaths from COVID-19 remain at 1 per cent of their pandemic peak on Aug 22, according to statistics compiled by the online database Our World in Data.
Health Minister Jose Angel Portal Miranda said the threat from Omicron had prompted Cuba to fast-track its booster campaign, and that all those eligible would have a booster shot in January, according to the state news outlet CubaDebate.
Cuba has already administered nearly 1.5 million boosters in the capital Havana, and to high risk groups such as health care workers. That campaign will now spread across the island in the coming weeks.
The nation has vaccinated 92 per cent of its population with at least one shot, and 85 per cent with a full course, of its homegrown vaccines, according to Our World in Data.
That puts it second in the world behind only the United Arab Emirates, among countries of at least 1 million people.
Cuba has vaulted ahead of its neighbours in Latin America and other emerging economies by developing its own vaccines instead of competing for those produced by wealthier nations.
Officials say Cuba’s protein-based shots – Abdala, Soberana 02 and Soberana Plus – give upwards of 90 per cent protection against symptomatic COVID-19 when offered in three-dose schemes, though those claims have yet to be fully vetted in peer-reviewed journals, or by the World Health Organization.
Cuban scientists had previously called for boosters to be given six months after the first three shots, but have now halved that time, the CubaDebate report said.
As Omicron looms, Amazon caps how many COVID-19 tests shoppers can buy
Dec 22 (Reuters) – Amazon.com Inc is limiting sales of its own at-home COVID-19 test kits to ten units per customer following actions taken by retailers including Walmart Inc (WMT.N) and CVS Health Corp (CVS.N), as more people test for the Omicron variant of the coronavirus.
The fast-spreading variant has become dominant in the United States and testing has rapidly risen as many consumers make plans for holiday travel and shopping.
Amazon’s own COVID-19 Test Collection Kit and iHealth’s COVID-19 Antigen Rapid Test were unavailable on the e-commerce site.
An Amazon spokesperson said the company is facing inventory shortages on some COVID-19 tests due to increased demand.
The company on its website asked customers to not collect or mail samples starting Wednesday to Sunday as they will not be shipped to laboratories and due to holiday schedules at package delivery company United Parcel Service (UPS.N).
The Amazon spokesperson said the company has also allowed third-party sellers to set their own limits on how many test kits can be sold on its website.
Walmart set a limit of eight tests for each online order, while CVS capped sales of test kits to six per person. Walgreens Boots Alliance Inc (WBA.O) said it would limit both online and in-store purchases of test kits to four per customer. read more
Reporting by Nivedita Balu in Bengaluru; Additional reporting by Chavi Mehta in Bengaluru; Editing by Maju Samuel
Our Standards: The Thomson Reuters Trust Principles.